Literature DB >> 30561701

High Compliance Rates With Patient-Reported Outcomes in Oncology Trials Submitted to the US Food and Drug Administration.

Ethan Basch1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30561701     DOI： 10.1093/jnci/djy183

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Reporting Standards for Patient-Reported Outcomes in Clinical Trial Protocols and Publications.

Authors:  Ethan Basch; Allison Barz Leahy
Journal:  J Natl Cancer Inst       Date:  2019-11-01       Impact factor: 13.506

2.  Do reminder emails and past due notifications improve patient completion and institutional data submission for patient-reported outcome measures?

Authors:  Stephanie L Pugh; Joseph P Rodgers; Jennifer Moughan; Roseann Bonanni; Jaskaran Boparai; Ronald C Chen; James J Dignam; Deborah W Bruner
Journal:  Qual Life Res       Date:  2020-09-07       Impact factor: 4.147

3.  How Did a Multi-Institutional Trial Show Feasibility of Electronic Data Capture in Older Patients With Cancer? Results From a Multi-Institutional Qualitative Study (Alliance A171902).

Authors:  Nichole A Martin; Elizabeth S Harlos; Kathryn D Cook; Jennifer M O'Connor; Andrew Dodge; Emily Guerard; Jacqueline M Lafky; Aminah Jatoi; Jennifer G Le-Rademacher
Journal:  JCO Clin Cancer Inform       Date:  2021-04

4.  Collection of Post-treatment PRO Data in Oncology Clinical Trials.

Authors:  J Jason Lundy; Cheryl D Coon; An-Chen Fu; Vivek Pawar
Journal:  Ther Innov Regul Sci       Date:  2020-07-08       Impact factor: 1.778

5.  Effect of Collaborative Review of Electronic Patient-Reported Outcomes for Shared Reporting in Breast Cancer Patients: Descriptive Comparative Study.

Authors:  Andreas Trojan; Basil Bättig; Meinrad Mannhart; Burkhardt Seifert; Mathis N Brauchbar; Marco Egbring
Journal:  JMIR Cancer       Date:  2021-03-17

Review 6.  Investigating the impact of open label design on patient-reported outcome results in prostate cancer randomized controlled trials.

Authors:  Guillaume Mouillet; Fabio Efficace; Antoine Thiery-Vuillemin; Emilie Charton; Mieke Van Hemelrijck; Francesco Sparano; Amélie Anota
Journal:  Cancer Med       Date:  2020-08-26       Impact factor: 4.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.